Mycobacterial growth in human macrophages: Variation according to donor, inoculum and bacterial strain

被引:28
作者
Hoal-Van Helden, EG
Hon, D
Lewis, LA
Beyers, N
Van Helden, PD
机构
[1] Univ Stellenbosch, Fac Med, Dept Med Biochem, ZA-7505 Tygerberg, South Africa
[2] Univ Stellenbosch, Fac Med, MRC, Ctr Cellular & Mol Biol, ZA-7505 Tygerberg, South Africa
[3] Univ Stellenbosch, Fac Med, Dept Paediat, ZA-7505 Tygerberg, South Africa
关键词
BCG; M; tuberculosis; strains; human macrophages; infection; growth;
D O I
10.1006/cbir.2000.0679
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The microbicidal capacity of the macrophage is frequently evaded by mycobacteria, leading to tuberculosis (TB). We investigated a number of parameters affecting the rate of growth of mycobacteria in human monocyte-derived macrophages (MDM). The results show a great deal of variation in the growth of both Mycobacterium bovis BCG and M. tuberculosis H37Rv, using a large number of human macrophage donors, (132 and 40, respectively), but no correlation was seen with the TB status of the MDM donor. Clumping of the mycobacteria resulted in more vigorous growth in MDM, suggesting that inoculum size could affect disease progression. The growth rates of 17 clinical isolates of M. tuberculosis were measured in macrophages derived from three donors and no consistent or marked differences between isolates were observed over the 5-day period of growth measurement. However, all 17 clinical strains grew consistently faster than H37Rv in the same experiments. (C) 2001 Academic Press.
引用
收藏
页码:71 / 81
页数:11
相关论文
共 59 条
[1]   Variations in the Nrampi gene and susceptibility to tuberculosis in West Africans [J].
Bellamy, R ;
Ruwende, C ;
Corrah, T ;
McAdam, KPWJ ;
Whittle, HC ;
Hill, AVS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) :640-644
[2]  
BERMUDEZ LE, 1993, CLIN EXP IMMUNOL, V91, P277
[3]  
BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[4]  
Beyers N, 1996, S AFR MED J, V86, P40
[5]   Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility [J].
Blackwell, JM .
MOLECULAR MEDICINE TODAY, 1996, 2 (05) :205-211
[6]   TUBERCULOSIS - BACK TO A FRIGHTENING FUTURE [J].
BLOOM, BR .
NATURE, 1992, 358 (6387) :538-539
[7]  
Boyum A., 1968, SCAND J CLIN LAB INV, V21, P97
[8]   CAPACITY OF HUMAN-NEUTROPHILS TO KILL MYCOBACTERIUM-TUBERCULOSIS [J].
BROWN, AE ;
HOLZER, TJ ;
ANDERSEN, BR .
JOURNAL OF INFECTIOUS DISEASES, 1987, 156 (06) :985-989
[9]   THE PROTECTIVE IMMUNE-RESPONSE TO MYCOBACTERIUM-TUBERCULOSIS [J].
COOPER, AM ;
FLYNN, JL .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (04) :512-516
[10]   RELATIVE PERMISSIVENESS OF MACROPHAGES FROM BLACK AND WHITE PEOPLE FOR VIRULENT TUBERCLE-BACILLI [J].
CROWLE, AJ ;
ELKINS, N .
INFECTION AND IMMUNITY, 1990, 58 (03) :632-638